Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Nov;119(5):813–818. doi: 10.1111/j.1476-5381.1996.tb15745.x

Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats.

M Gariboldi 1, P Tutka 1, R Samanin 1, A Vezzani 1
PMCID: PMC1915949  PMID: 8922726

Abstract

1. We studied whether the stimulation of 5-HT1A receptors by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), a specific 5-HT1A receptor agonist, reduced electroencephalographic (EEG) seizures induced by intrahippocampal injection of 0.04 microgram in 0.5 microliter of the glutamate analogue kainic acid in freely-moving rats. 2. Pretreatment with 8-OH-DPAT 15 min earlier at the same site as kainic acid injection, caused a dose-dependent decrease of kainic acid-induced seizure activity. One and 10 micrograms significantly reduced the total time spent in seizures by 72% on average and the total number of seizures by 58% (P < 0.01) and 43% (P < 0.05) respectively. The latency to onset of the first seizure was increased 2.8 times (P < 0.01) only after 1 microgram 8-OH-DPAT; 0.1 microgram was ineffective on all seizure parameters. 3. Systemic administration of 25, 100 and 1000 micrograms kg-1 8-OH-DPAT significantly reduced the total number of seizures and the total time in seizures induced by intrahippocampal kainic acid by 52% and 74% on average. The latency to onset of the first seizure was delayed 1.8 times by 100 and 1000 micrograms kg-1 (P < 0.05). 4. The anticonvulsant action of 8-OH-DPAT given intrahippocampally or systemically was significantly blocked by 5 micrograms, but not 1 microgram WAY 100635, a selective 5-HT1A receptor antagonist, administered in the hippocampus before the agonist. 5. These results indicate that postsynaptic 5-HT1A receptors in the hippocampus mediate the anticonvulsant action of 8-OH-DPAT and that their stimulation has an inhibitory role in the generation of limbic seizures.

Full text

PDF
813

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvidsson L. E., Hacksell U., Nilsson J. L., Hjorth S., Carlsson A., Lindberg P., Sanchez D., Wikstrom H. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem. 1981 Aug;24(8):921–923. doi: 10.1021/jm00140a002. [DOI] [PubMed] [Google Scholar]
  2. Azmitia E. C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol. 1978 Jun 1;179(3):641–667. doi: 10.1002/cne.901790311. [DOI] [PubMed] [Google Scholar]
  3. Baskys A., Niesen C. E., Davies M. F., Carlen P. L. Modulatory actions of serotonin on ionic conductances of hippocampal dentate granule cells. Neuroscience. 1989;29(2):443–451. doi: 10.1016/0306-4522(89)90071-7. [DOI] [PubMed] [Google Scholar]
  4. Beck S. G., Choi K. C. 5-Hydroxytryptamine hyperpolarizes CA3 hippocampal pyramidal cells through an increase in potassium conductance. Neurosci Lett. 1991 Nov 25;133(1):93–96. doi: 10.1016/0304-3940(91)90065-2. [DOI] [PubMed] [Google Scholar]
  5. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 1985 Feb;14(2):375–403. doi: 10.1016/0306-4522(85)90299-4. [DOI] [PubMed] [Google Scholar]
  6. Carli M., Lazarova M., Tatarczynska E., Samanin R. Stimulation of 5-HT1A receptors in the dorsal hippocampus impairs acquisition and performance of a spatial task in a water maze. Brain Res. 1992 Nov 6;595(1):50–56. doi: 10.1016/0006-8993(92)91451-j. [DOI] [PubMed] [Google Scholar]
  7. Carli M., Luschi R., Samanin R. (S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Eur J Pharmacol. 1995 Sep 5;283(1-3):133–139. doi: 10.1016/0014-2999(95)00310-h. [DOI] [PubMed] [Google Scholar]
  8. Carli M., Samanin R. 8-Hydroxy-2-(di-n-propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A receptors. Br J Pharmacol. 1992 Mar;105(3):720–726. doi: 10.1111/j.1476-5381.1992.tb09045.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clark M., Weiss S. R., Post R. M. Autoradiographic analysis of serotonin receptors and transporter in kindled rat brain. Neurosci Lett. 1993 Oct 14;161(1):21–26. doi: 10.1016/0304-3940(93)90130-d. [DOI] [PubMed] [Google Scholar]
  10. Corradetti R., Ballerini L., Pugliese A. M., Pepeu G. Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience. 1992;46(3):511–518. doi: 10.1016/0306-4522(92)90140-w. [DOI] [PubMed] [Google Scholar]
  11. De la Torre J. C., Kawanaga H. M., Mullan S. Seizure susceptibility after manipulation of brain serotonin. Arch Int Pharmacodyn Ther. 1970 Dec;188(2):298–304. [PubMed] [Google Scholar]
  12. Elwes R. D., Johnson A. L., Shorvon S. D., Reynolds E. H. The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med. 1984 Oct 11;311(15):944–947. doi: 10.1056/NEJM198410113111503. [DOI] [PubMed] [Google Scholar]
  13. Favale E., Rubino V., Mainardi P., Lunardi G., Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology. 1995 Oct;45(10):1926–1927. doi: 10.1212/wnl.45.10.1926. [DOI] [PubMed] [Google Scholar]
  14. Ferkany J. W., Coyle J. T. Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids. J Pharmacol Exp Ther. 1983 May;225(2):399–406. [PubMed] [Google Scholar]
  15. French E. D., Aldinio C., Schwarcz R. Intrahippocampal kainic acid, seizures and local neuronal degeneration: relationships assessed in unanesthetized rats. Neuroscience. 1982 Oct;7(10):2525–2536. doi: 10.1016/0306-4522(82)90212-3. [DOI] [PubMed] [Google Scholar]
  16. Ghadimi B. M., Jarolimek W., Misgeld U. Effects of serotonin on hilar neurons and granule cell inhibition in the guinea pig hippocampal slice. Brain Res. 1994 Jan 7;633(1-2):27–32. doi: 10.1016/0006-8993(94)91518-0. [DOI] [PubMed] [Google Scholar]
  17. Invernizzi R., Belli S., Samanin R. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 1992 Jul 3;584(1-2):322–324. doi: 10.1016/0006-8993(92)90914-u. [DOI] [PubMed] [Google Scholar]
  18. Invernizzi R., Bramante M., Samanin R. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res. 1995 Oct 23;696(1-2):62–66. doi: 10.1016/0006-8993(95)00730-e. [DOI] [PubMed] [Google Scholar]
  19. Kovacs D. A., Zoll J. G. Seizure inhibition by median raphe nucleus stimulation in rat. Brain Res. 1974 Apr 12;70(1):165–169. doi: 10.1016/0006-8993(74)90224-8. [DOI] [PubMed] [Google Scholar]
  20. Lazarova M., Przewłocka B., Mogilnicka E., Stala L. The effect of L-DOPA and L-5-hydroxytryptophan on the pentetrazole seizures in rats after lesions of the median raphe nucleus and substantia nigra. Pol J Pharmacol Pharm. 1979 Nov-Dec;31(6):547–554. [PubMed] [Google Scholar]
  21. Löscher W., Czuczwar S. J. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy. Neurosci Lett. 1985 Sep 30;60(2):201–206. doi: 10.1016/0304-3940(85)90244-7. [DOI] [PubMed] [Google Scholar]
  22. MacGregor D. G., Stone T. W. Prevention of kainate-induced excitotoxicity by a purine analogue. Neuroreport. 1992 Jun;3(6):536–538. doi: 10.1097/00001756-199206000-00022. [DOI] [PubMed] [Google Scholar]
  23. Mattson R. H., Cramer J. A., Collins J. F., Smith D. B., Delgado-Escueta A. V., Browne T. R., Williamson P. D., Treiman D. M., McNamara J. O., McCutchen C. B. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. 1985 Jul 18;313(3):145–151. doi: 10.1056/NEJM198507183130303. [DOI] [PubMed] [Google Scholar]
  24. Maura G., Roccatagliata E., Ulivi M., Raiteri M. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors. Eur J Pharmacol. 1988 Jan 5;145(1):31–38. doi: 10.1016/0014-2999(88)90345-7. [DOI] [PubMed] [Google Scholar]
  25. McDonald J. W., Johnston M. V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev. 1990 Jan-Apr;15(1):41–70. doi: 10.1016/0165-0173(90)90011-c. [DOI] [PubMed] [Google Scholar]
  26. Oleskevich S., Descarries L. Quantified distribution of the serotonin innervation in adult rat hippocampus. Neuroscience. 1990;34(1):19–33. doi: 10.1016/0306-4522(90)90301-j. [DOI] [PubMed] [Google Scholar]
  27. Pompeiano M., Palacios J. M., Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci. 1992 Feb;12(2):440–453. doi: 10.1523/JNEUROSCI.12-02-00440.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ropert N. Inhibitory action of serotonin in CA1 hippocampal neurons in vitro. Neuroscience. 1988 Jul;26(1):69–81. doi: 10.1016/0306-4522(88)90128-5. [DOI] [PubMed] [Google Scholar]
  29. Salgado D., Alkadhi K. A. Inhibition of epileptiform activity by serotonin in rat CA1 neurons. Brain Res. 1995 Jan 16;669(2):176–182. doi: 10.1016/0006-8993(94)01235-a. [DOI] [PubMed] [Google Scholar]
  30. Schwarcz R., Meldrum B. Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders. Lancet. 1985 Jul 20;2(8447):140–143. doi: 10.1016/s0140-6736(85)90238-7. [DOI] [PubMed] [Google Scholar]
  31. Sizer A. R., Kilpatrick G. J., Roberts M. H. A post-synaptic depressant modulatory action of 5-hydroxytryptamine on excitatory amino acid responses in rat entorhinal cortex in vitro. Neuropharmacology. 1992 Jun;31(6):531–539. doi: 10.1016/0028-3908(92)90184-q. [DOI] [PubMed] [Google Scholar]
  32. Vezzani A., Serafini R., Stasi M. A., Viganò G., Rizzi M., Samanin R. A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacology. 1991 Apr;30(4):345–352. doi: 10.1016/0028-3908(91)90059-k. [DOI] [PubMed] [Google Scholar]
  33. Vezzani A., Wu H. Q., Tullii M., Samanin R. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments. J Pharmacol Exp Ther. 1986 Oct;239(1):256–263. [PubMed] [Google Scholar]
  34. Wada Y., Nakamura M., Hasegawa H., Yamaguchi N. Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci Lett. 1993 Sep 3;159(1-2):179–182. doi: 10.1016/0304-3940(93)90828-9. [DOI] [PubMed] [Google Scholar]
  35. Whitton P. S., Oresković D., Jernej B., Bulat M. Effect of valproic acid on 5-hydroxytryptamine turnover in mouse brain. J Pharm Pharmacol. 1985 Mar;37(3):199–200. doi: 10.1111/j.2042-7158.1985.tb05040.x. [DOI] [PubMed] [Google Scholar]
  36. Whitton P. S., Oresković D., Marković Z., Skarpa D., Bulat M. Effect of the antiepileptic di-n-propylacetamide on 5-hydroxytryptamine turnover in the brain and 5-hydroxyindoleacetic acid level in the cerebrospinal fluid. Eur J Pharmacol. 1983 Jul 15;91(1):57–62. doi: 10.1016/0014-2999(83)90361-8. [DOI] [PubMed] [Google Scholar]
  37. Yan Q. S., Jobe P. C., Dailey J. W. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol. 1994 Jan 24;252(1):105–112. doi: 10.1016/0014-2999(94)90581-9. [DOI] [PubMed] [Google Scholar]
  38. Zhang G., Franklin P. H., Murray T. F. Anticonvulsant effect of N-ethylcarboxamidoadenosine against kainic acid-induced behavioral seizures in the rat prepiriform cortex. Neurosci Lett. 1990 Jul 13;114(3):345–350. doi: 10.1016/0304-3940(90)90588-z. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES